Výsledky vyhledávání - Gerd Reifschneider
- Zobrazuji výsledky 1 - 4 z 4
-
1
Switching from natalizumab to fingolimod Autor Ludwig Kappos, Ernst‐Wilhelm Radue, Gıancarlo Comı, Xavier Montalbán, Helmut Butzkueven, Heinz Wiendl, Gavin Giovannoni, Hans‐Peter Hartung, Tobias Derfuß, Yvonne Naegelin, Till Sprenger, Nicole Mueller‐Lenke, Sarah Griffiths, Philipp von Rosenstiel, Rebecca Gottschalk, Ying Zhang, Frank Dahlke, Davorka Tomic, Helmut Butzkueven, Richard Macdonell, Eva-Maria Maida, Veronika Tichá, Marta Vachová, Eva Meluzínová, Mikko Kallela, Heinz Wiendl, Kerstin Hellwig, Markus Maeurer, Johannes Boehringer, Wilfried Lueer, Hans-Juergen von Giesen, Arnfin Bergmann, Andreas Bitsch, Thomas Brosch, Peter Emrich, Klaus Gehring, Michael Lang, Gerd Reifschneider, Gerhard Roth, Eugen Schlegel, Sylke Schlemilch-Paschen, Erik Strauss, Joerg Osterhage, Andreas Link, Andreas Steinbrecher, Nikolaos Vlaikidis, Antonios Tavernarakis, Nikolaos Fakas, Marinos C. Dalakas, Athanasios P. Kyritsis, Magdolna Simó, Gyula Pánczél, Ron Milo, Adi Vaknin, Cristoforo Comi, Luigi Maria Grimaldi, Xavier Montalbán, Guillermo Izquierdo, Óscar Fernández Fernández, Antonio Escartin Siquier, E. L. García Diez, Ludwig Kappos
Vydáno 2015Editorial -
2
Long-term safety and efficacy of teriflunomide Autor Paul O’Connor, Cristoforo Comi, Mark S. Freedman, Aaron Miller, Ludwig Kappos, Jean‐Pierre Bouchard, Christine Lebrun‐Frénay, Jan Mareš, Myriam Bénamor, Karthinathan Thangavelu, Jinjun Liang, Philippe Truffinet, Victoria Lawson, Jerry S. Wolinsky, E. Maida, Eduard Auff, Franz Fazekas, Thomas Berger, Virender Bhan, J-P Bouchard, Pierre Duquette, Mark S. Freedman, François Grand’Maison, M. Kremenchutzky, Caitlin Bourque, Ruth Ann Marrie, Maria Melanson, D. Patry, Paul O’Connor, Joël Oger, Mark Stefanelli, François Jacques, Pablo Venegas, Manoel Miranda, N. Barrientos, E Tenhamm, Sergio Gloger, Gernot Rohde, Jan Mareš, Jette Lautrup Frederiksen, Egon Stenager, Sulev Haldre, Katrin Gross‐Paju, Irina Elovaara, M-L Sumelahti, J-P Erälinna, J-P Erälinna, Martti Färkkilâ, Hanna Harno, Mauri Reunanen, T. Jolma, Cyrille B. Confavreux, William Camu, Pierre Clavelou, Laurent Magy, Marc Debouverie, Gilles Edan, Christine Lebrun‐Frénay, T. Moreau, Jean Pelletier, E Roullet, Sonia Alamowitch, M. Clanet, Patrick Hautecœur, Philippe Damier, L. Rumbach, Andrew Chan, Sebastian Schimrigk, J. Haas, Eckart Lensch, Hans‐Christoph Diener, Volker Limmroth, D. Anders, Martin Berghoff, Patrick Oschmann, Martin Stangel, Martin Berghoff, Achim Frese, Reinhard Kiefer, Martin Marziniak, Uwe K. Zettl, E. Stark, K. Jendroska, Gerd Reifschneider, Mauro Amato, Giacomo P. Comi, V. Cosi, Pamela Gallo, Claudio Gasperini, Angelo Ghezzi, María Trojano, Carlo Pozzilli, E. Montanari, Cees Zwanikken, P.J.H. Jongen, E.Th.L. van Munster, Raymond Hupperts, Bert W.M. Anten, E.A.C.M. Sanders, E. Celius
Vydáno 2016Artigo -
3
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial Autor Bruce Cree, Gary Cutter, Jerry S. Wolinsky, Mark S. Freedman, Gıancarlo Comı, Gavin Giovannoni, Hans-Peter Hartung, Douglas L. Arnold, Jens Kühle, Valerie J. Block, Frederick Munschauer, Frédéric Sedel, Fred Lublin, Stephen C. Reingold, Pierre Duquette, Tobias Derfuß, Franz Fazekas, Maria Pia Sormani, Robert P. Lisak, Jennifer Graves, Stephen Krieger, Rana Zabad, Scott D. Newsome, Joshua Barton, Richard Macdonell, Mark Marriott, Nina De Klippel, Guy Laureys, Barbara Willekens, Virginia Devonshire, Mark S. Freedman, J Girard, Paul S. Giacomini, Roger McKelvey, Daniel Selchen, Galina Vorobeychik, Ludivine Chamard Witkowski, Radek Ampapa, Jana Lízrová Preiningerová, Eva Meluzínová, Radomír Taláb, Marta Vachová, Orhan Aktaş, Mathias Buttmann, Elias-Hamp Birte, Tania Kuempfel, Friedemann Paul, Daniela Rau, Gerd Reifschneider, Piotr Sokolowski, Hayrettin Tumani, Mária Sátori, Carlo Pozzilli, Agata Klosek, Jozef Koscielniak, Waldemar Fryze, Małgorzata Zajda, Rafael Arroyo González, Guillermo Izquierdo Ayuso, Victoria Fernández Sánchez, Celia Oreja Guevara, Jose Enrique Martinez Rodriguez, Xavier Montalbán, Lluís Ramió‐Torrentà, Lou Brundin, Jan Lycke, Murat Terzi, Joe Guadagno, Don J. Mahad, Adrian Pace, Klaus Schmierer, Ahmed Toosy, Stewart Webb, Mark Agius, Lilyana Amezcua, Michelle Apperson, Bridget Bagert, Daniel S. Bandari, Evanthia Bernitsas, Jonathan Calkwood, Jonathan Carter, Bruce A. Cohen, Devon Conway, Joanna Cooper, John R. Corboy, Patricia K. Coyle, Bruce Cree, Mitchel Freedman, Corey C. Ford, Edward Fox, Myla Goldman, Benjamin Greenberg, Mariko Kita, Thomas Leist, Sharon Lynch, Aaron Miller, Harold Moses, Robert T. Naismith, Mary Ann Picone, Perminder Bhatia
Vydáno 2020Artigo -
4
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis Autor Patrick Vermersch, Luís Brieva, Robert J. Fox, Friedemann Paul, Lluís Ramió‐Torrentà, Matthias Schwab, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Maciej Maciejowski, Nassima Hecham, Norma Deri, Jasminka Djelilović-Vranić, Ivan Milanov, Penko Shotekov, Gregg Blevins, J Girard, Yves Lapierre, William Camu, Giovanni Castelnovo, Pierre Clavelou, Patrick Hautecœur, Martin Marziniak, Christoph Mayer, Patrick Oschmann, Gerd Reifschneider, I. Schoell, Björn Tackenberg, Florian Then Bergh, Ν. Fakas, Nikolaos Grigoriadis, D. Kalochristianakis, Dimos D. Mitsikostas, Anastasios Orologas, Antonios Tavernarakis, Thomas Thomaidis, Krisztina Kovács, K Mátyás, Pálma Piros, Mária Sátori, K.J.S. Anand, Alexander L. Shifrin, Krzysztof Banaszkiewicz, Robert Bonek, M. Chahwan, M. Czernichowska - Kotiuszko, Lidia Darda-Ledzion, J. D. Wojcik, M Dziki, Ewa Krzystanek, Marianna Kulka, Paweł Lisewski, Marcin Ratajczak, Andrzej Szczudlik, Jarosław Szczygieł, Małgorzata Pańczyk-Tomaszewska, Jacek Wójcik, Daniel Zielonka, M. Chiru, Swaroopa Deme, S Mănescu, S.A. Nica, Christian Popescu, Szabolcs Szatmári, A. L. Fedyanin, N A Malkova, D.V. Popov, Л. И. Волкова, Vorob'eva Ov, M Brozman, Andrea Cimprichová, P. Cuchran, Ladislav Gurcik, Georgi Krastev, I. Lisá, M. Nyeky, J. Poljaková, Peter Turčáni, Adaani Frost, Josef G. Heckmann, Eduardo Agüera, Francisco Coret, Antonio Escartín, Victoria Fernández, JR. Ara Callizo, Greg S. Martin, José Rodríguez, M. Martinez Gines, Daniel Muñoz, Javier Olascoaga, José M. Prieto, Cristina Ramo‐Tello, Samir Belal, S. Ben Ammou, Mahbouba Frih-Ayed, Riadh Gouider, Chokri Mhiri, Ridha Mrissa, Alla Cherkez, H. Chmyr
Vydáno 2022Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Multiple sclerosis
Alternative medicine
Pathology
Placebo
Psychiatry
Expanded Disability Status Scale
Fingolimod
Adverse effect
Clinical endpoint
Clinical trial
Confidence interval
Gastroenterology
Immunology
Natalizumab
Oncology
Pediatrics
Physical therapy
Randomized controlled trial
Surgery
Teriflunomide